Every material Form 8-K GABELLI EQUITY TRUST INC filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
The Fund disclosed that Mario J. Gabelli, its Trustee and Chairman and Chief Investment Officer, was admitted to hospital for observation and testing after a medical incident on March 19, 2026, and that his condition is improving with the timeline for his return not yet known. Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi are leading the Fund's portfolio management team in his absence, which matters to shareholders because day-to-day investment leadership has changed.
Mario J. Gabelli was admitted to hospital after a medical incident on March 19, 2026; his condition is improving, but no return date has been set.
On March 22, 2026, GAMCO implemented a succession plan under which Christopher J. Marangi was named President of GAMCO.
Kevin V. Dreyer and Christopher J. Marangi lead the Fund's portfolio management team during Mr. Gabelli's absence.
Douglas R. Jamieson and Christopher J. Marangi will continue to lead GAMCO's day-to-day operations.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every GABELLI EQUITY TRUST INC filing is on SEC EDGAR ↗. 8-K briefs of other companies →